abstract |
The present invention relates to a compound of formula (I) The use of substituted 3- (4-hydroxyphenyl) -indoline-2-one compounds (oxindole compounds) represented by formula (I) and the use of such compounds for the manufacture of a medicament for the treatment of cancer in mammals, particularly humans. Disclose. |